THE COOPER COMPANIES, INC

NASDAQ: COO (The Cooper Companies, Inc.)

Last update: 03 Oct, 9:27PM

70.46

1.34 (1.94%)

  • 1D 1.94%
  • 5D 0.50%
  • 1M 7.61%
  • 6M -9.43%
  • YTD -22.28%
  • 1Y -35.09%
  • 5Y -20.25%
Previous Close 69.12
Open 69.26
Volume 1,547,115
Avg. Volume (3M) 2,675,656
Market Cap 14,008,077,312
Price / Earnings (TTM) 34.54
Price / Earnings (Forward) 15.97
Price / Sales 3.43
Price / Book 1.65
52 Weeks Range
61.78 (-12%) — 109.37 (55%)
Earnings Date 4 Dec 2025
Profit Margin 10.39%
Operating Margin (TTM) 18.44%
Diluted EPS (TTM) 2.07
Quarterly Revenue Growth (YOY) 6.30%
Quarterly Earnings Growth (YOY) -1.40%
Total Debt/Equity (MRQ) 34.50%
Current Ratio (MRQ) 2.10
Operating Cash Flow (TTM) 762.40 M
Levered Free Cash Flow (TTM) 229.68 M
Return on Assets (TTM) 3.88%
Return on Equity (TTM) 5.15%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Mixed
Medical Instruments & Supplies (Global) Mixed Bearish
Stock The Cooper Companies, Inc. Bearish Bearish

AIStockmoo Score

0.8
Analyst Consensus -0.5
Insider Activity NA
Price Volatility 1.5
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average 0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
COO 14 B - 34.54 1.65
HOLX 14 B - 27.24 3.12
ALGN 9 B - 21.74 2.38
ISRG 182 B - 78.73 8.90
MMSI 5 B - 41.98 3.28
LMAT 2 B 0.88% 42.32 5.42

CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Mid Core
% Held by Insiders 0.62%
% Held by Institutions 102.58%
52 Weeks Range
61.78 (-12%) — 109.37 (55%)
Price Target Range
64.00 (-9%) — 94.00 (33%)
High 94.00 (Needham, 33.41%) Buy
Median 83.00 (17.80%)
Low 64.00 (Goldman Sachs, -9.17%) Sell
Average 79.27 (12.50%)
Total 7 Buy, 3 Hold, 1 Sell
Avg. Price @ Call 66.06
Firm Date Target Price Call Price @ Call
Barclays 13 Oct 2025 85.00 (20.64%) Buy 69.30
Goldman Sachs 01 Oct 2025 64.00 (-9.17%) Sell 68.07
Baird 28 Aug 2025 85.00 (20.64%) Buy 64.58
Citigroup 28 Aug 2025 72.00 (2.19%) Hold 64.58
JP Morgan 28 Aug 2025 66.00 (-6.33%) Hold 64.58
Morgan Stanley 28 Aug 2025 76.00 (7.86%) Hold 64.58
Needham 28 Aug 2025 94.00 (33.41%) Buy 64.58
Piper Sandler 28 Aug 2025 83.00 (17.80%) Buy 64.58
Stifel 28 Aug 2025 85.00 (20.64%) Buy 64.58
Wells Fargo 28 Aug 2025 72.00 (2.19%) Buy 64.58
Mizuho 16 Jul 2025 90.00 (27.73%) Buy 72.70
Show more

No data within this time range.

5Y Average Dividend Yield 0.05%
Ex Date Announcement Date Payment Date Details
26 Jul 2023 11 Jul 2023 11 Aug 2023 0.03 Cash
20 Jan 2023 13 Dec 2022 10 Feb 2023 0.03 Cash
26 Jul 2022 13 Jul 2022 11 Aug 2022 0.03 Cash
20 Jan 2022 07 Dec 2021 09 Feb 2022 0.03 Cash
26 Jul 2021 13 Jul 2021 11 Aug 2021 0.03 Cash
21 Jan 2021 09 Dec 2020 09 Feb 2021 0.03 Cash
22 Jul 2020 09 Jul 2020 07 Aug 2020 0.03 Cash
22 Jan 2020 10 Dec 2019 10 Feb 2020 0.03 Cash
22 Jul 2019 10 Jul 2019 07 Aug 2019 0.03 Cash
18 Jan 2019 12 Dec 2018 08 Feb 2019 0.03 Cash
20 Jul 2018 11 Jul 2018 07 Aug 2018 0.03 Cash
22 Jan 2018 12 Dec 2017 09 Feb 2018 0.03 Cash
19 Jul 2017 06 Jul 2017 07 Aug 2017 0.03 Cash
19 Jan 2017 14 Dec 2016 09 Feb 2017 0.03 Cash
20 Jul 2016 14 Jun 2016 05 Aug 2016 0.03 Cash
20 Jan 2016 10 Dec 2015 09 Feb 2016 0.03 Cash
22 Jul 2015 23 Jun 2015 06 Aug 2015 0.03 Cash
21 Jan 2015 08 Jan 2015 09 Feb 2015 0.03 Cash
22 Jul 2014 10 Jul 2014 06 Aug 2014 0.03 Cash
22 Jan 2014 08 Jan 2014 07 Feb 2014 0.03 Cash
22 Jul 2013 11 Jul 2013 06 Aug 2013 0.03 Cash
23 Jan 2013 08 Jan 2013 07 Feb 2013 0.03 Cash
20 Jul 2012 11 Jul 2012 06 Aug 2012 0.03 Cash
23 Jan 2012 05 Jan 2012 07 Feb 2012 0.03 Cash
21 Jul 2011 13 Jul 2011 05 Aug 2011 0.03 Cash
14 Jan 2011 06 Jan 2011 07 Feb 2011 0.03 Cash
16 Jul 2010 08 Jul 2010 05 Aug 2010 0.03 Cash
14 Jan 2010 08 Jan 2010 05 Feb 2010 0.03 Cash
16 Jul 2009 09 Jul 2009 05 Aug 2009 0.03 Cash
14 Jan 2009 07 Jan 2009 05 Feb 2009 0.03 Cash
11 Jun 2008 15 May 2008 03 Jul 2008 0.03 Cash
12 Dec 2007 30 Nov 2007 04 Jan 2008 0.03 Cash
11 Jun 2007 10 May 2007 05 Jul 2007 0.03 Cash
13 Dec 2006 30 Nov 2006 05 Jan 2007 0.03 Cash
12 Jun 2006 11 May 2006 05 Jul 2006 0.03 Cash
14 Dec 2005 02 Dec 2005 05 Jan 2006 0.03 Cash
10 Jun 2005 13 May 2005 05 Jul 2005 0.03 Cash
14 Dec 2004 02 Dec 2004 05 Jan 2005 0.03 Cash
13 Sep 2000 06 Sep 2000 05 Oct 2000 0.02 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2023 0.060 2 0.06
2022 0.060 2 0.07
2021 0.060 2 0.06
2020 0.060 2 0.07
2019 0.060 2 0.08
2018 0.060 2 0.09
2017 0.060 2 0.11
2016 0.060 2 0.14
2015 0.060 2 0.18
2014 0.060 2 0.15
2013 0.060 2 0.19
2012 0.060 2 0.26
2011 0.060 2 0.34
2010 0.060 2 0.43
2009 0.060 2 0.63
2008 0.060 2 1.46
2007 0.060 2 0.63
2006 0.060 2 0.54
2005 0.060 2 0.47
2000 0.020 1 0.40
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria